John Jack Leahy
University of Vermont
5 Papers
90 Citations
John Jack Leahy is an academic researcher from University of Vermont. The author has contributed to research in topics: Type 2 diabetes & Insulin. The author has an hindex of 3, co-authored 5 publications.
Chat about Author
Papers
An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia.
TL;DR: The objective is to evaluate the benefits of initiating insulin at an earlier versus later treatment stage, and regimens with/without sulfonylurea (SU).
77
Optimizing Postprandial Glucose Management in Adults With Insulin-Requiring Diabetes: Report and Recommendations.
John Jack Leahy,Grazia Aleppo,Vivian Fonseca,Satish K. Garg,Irl B. Hirsch,Anthony L McCall,Anthony L McCall,Janet B. McGill,William H. Polonsky +8 more
TL;DR: Managing PPG to minimize or prevent diabetes-related complications will require elucidating fundamental questions about optimal ways to quantify and clinically assess the metabolic dysregulation and consequences of the abnormal postprandial state in diabetes and recommend research strategies to address these questions.
Options for prandial glucose management in type 2 diabetes patients using basal insulin: addition of a short‐acting GLP‐1 analogue versus progression to basal‐bolus therapy
Irl B. Hirsch,John B. Buse,John Jack Leahy,Janet B. McGill,Anne L. Peters,Helena W. Rodbard,Richard R. Rubin,Jay S. Skyler,Carol A. Verderese,Matthew C. Riddle +9 more
TL;DR: This article considers how the addition of a glucagon‐like peptide 1 (GLP‐1) analogue to basal insulin may provide new opportunities at this stage of treatment, especially for patients concerned about weight gain and risk of hypoglycaemia.
12
Insulin treatment in managing type 2 diabetes: challenges and opportunities.
TL;DR: Following a stepwise approach to the management of type 2 diabetes, with early initiation of insulin therapy that ameliorates both fasting and postprandial hyperglycemia, can address the progressive increase in insulin resistance and decline in insulin secretion.